FilingSEC EDGAR8-K/A
Atrium Therapeutics, Inc. Files Amendment to Correct Post-Offering Share Count
· SEC accepted
StageAmendment
Filing content
Atrium Therapeutics, Inc. filed an amendment to its previous report to correct the number of shares outstanding following its recent offering.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…